Herpes viruses are a large family of viruses containing eight known human viruses. Amongst them, herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) cause cold sores and genital infections, respectively. 1) HSV infections are one of the most common contagious diseases in humans. Previous antiviral research on HSVs has primarily focused on the development of nucleoside analogs that target the viral polymerase.
lowed by direct condensation with 4-substituted-3-thiosemicarbazides. 7) Some thiosemicarbazides were purchased from commercial suppliers, and others were prepared from the corresponding isothiocyanate with 85% hydrazine hydrate in ethanol. It should be pointed out that compounds 5a-o were all racemates.
Compounds 7a and 7b were obtained by condensation in AcOH of 6 with aminoacetic acid and 4-aminobutyric acid, respectively. 8) Using the method of Wang et al., 9) the abromoketones 8a and 8b were prepared in good yields. Oxidation and condensation of compounds 8a and 8b afforded compounds 9a-d using the above method (Chart 2). Except 5g, other TDA analogues were new compounds.
This series of TDA analogues were evaluated for their anti-HSV activity in Vero cells. The cytotoxic activity of the compounds was determined in parallel in the same cell line.
The observed activities were compared with those of TDA and acyclovir (ACV). The subclass of compounds 5a-o had a wide variety of substituents on the 4Ј,4Љ-N residue. As can be seen in Table 1 , alkyl groups in 4Ј,4Љ-positions did not improve potency (5a-f). On the other hand, the introduction of aryl substituents in the same positions generally led to an increase in inhibitory potency (5g-o). Especially, a notable anti-HSV-1 activity was seen when a halogen atom was present at the 4-position on the phenyl ring (5i-k). Substituting the halogen atom at the 4-position for a methyl (5n) or a methoxy (5o) decreasesd the activity of the molecules. Compounds that showed good activity against HSV-1 and good separation between anti-HSV activity and toxicity were tested for activity against HSV-2. Several of the compounds showed activity similar to ACV against HSV-1 and HSV-2. However, compound 5l lost suppressant property against HSV-2. The most potent anti-HSV compounds were 5j and 5k, which showed marked inhibition of HSV-1 (IC 50 ϭ8.56 and 2.85 mg/ml, respectively) and HSV-2 (IC 50 ϭ1.75 and 4.11 mg/ml, respectively). Meanwhile they had low cytotoxicity (CC 50 Ͼ64.15 mg/ml), resulting in high selectivity index (SI HSV-1 ϭ7.49 and 27.03, SI HSV-2 ϭ36.8 and 18.7, respectively).
To study the effect of the chain between the phthalimide and bisthiosemicarbazone moieties, two alkyl linkers were introduced, producing the four analogous compounds 9a-d. The propylene analogues were 3-4 fold more potent than the corresponding methylene analogues ( Table 2 ). Like compounds 5j and 5k, compounds 9c and 9d demonstrated similar anti-HSV-1 potency with IC 50 s of less than 4.11 mg/ml. More importantly, compound 9d also exhibited a high selectivity index (SIϭ12.9). This result suggests that the alkyl linker is important for antiviral activity.
On the basis of the above-described results, the following conclusions could be drawn: (a) alkyl groups in the 4Ј,4Љ-positions are found to decrease activity; (b) aryl groups in the same positions generally increase activity; (c) a 4-halogenated aromatic ring results in good selectivity; and (d) the alkyl linker between the phthalimide and bisthiosemicarbazone moieties is important for antiviral activity. These results support further development of more specific and potent analogues for antiviral drug therapy. Additional efforts will be devoted to investigate the mechanism of antiviral action of these compounds.
Experimental
Biology. Antiviral Assay The antiviral activity of compounds 5a-o and 9a-d was determined using a cytopathic effect (CPE) reduction assay against HSV-1 (VR733) and HSV-2 (SAV) in Vero cell cultures. Cells grown to confluency in 96-well plates were infected with 100 CCID 50 of virus, one CCID 50 being the 50% cell culture infective dose. After an adsorption period of 2 h at 37°C, virus was removed and serial dilutions of the compounds were added. Virus-infected wells without compounds were used as cytopathogenicity controls. Viral cytopathogenicity was completed 1-2 d after viral infection. Antiviral activity is expressed as the IC 50 (50% inhibitory concentration).
Cytotoxic Assay Cytotoxicity of the compounds for the host cells was evaluated in parallel with their antiviral effects, based on the inhibition of cell growth.
Chemistry. General 1 H-NMR spectra were recorded on a Varian MER-CURY-300 (300 MHz) system. Chemical shift values (d) are given in ppm relative to TMS as internal standard. HR-MS spectra were obtained on a LC/MSD TOF spectrometer, using ESI as ionization mode. Flash column chromatography was performed with 200-300 mesh silica gel.
3-Phthalimido-2-butanone (2) To a solution of 3-chloro-2-butanone (3.21 g, 20 mmol) in DMF (20 ml) was added potassium phthalimide (6.12 g, 22 mmol) with stirring. The reaction mixture was stirred at room temperature for 3 h and then poured into water (180 ml). The desired product can be collected via filtration without further purification. Phthalimido-2-oxo-nbutyraldehyde-bis-(4-alkyl or aryl)thiosemicarbazone (5a-o) A solution of 3 (296 mg, 1 mmol) in DMSO/H 2 O (4 : 1, 2 ml) was heated at 80°C for 3 h. The appropriate thiosemicarbazide (2 mmol) in hot 95% ethanol was added and stirring under reflux was continued for 1-3 h, during which period a precipitate was formed. The precipitate was filtered, washed with ethanol, dried, and purified by flash chromatography on silica gel to afford 5a-o. 5a: 
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